Iran’s access to essential medicines is getting harder amid a fragile ceasefire with the United States and Israel, according to reports from multiple outlets. They say that longstanding constraints—particularly international sanctions, currency volatility, and pressure on insurers—have already made medical treatment difficult in Iran. The current war-related phase adds further strain by disrupting regional supply routes and damaging parts of Iran’s health and pharmaceutical infrastructure. In addition, payment systems and imports are described as being disrupted, limiting the ability of pharmacies and hospitals to obtain drugs. The combined effect is visible in everyday care: patients increasingly shop across multiple pharmacies in search of medicines, while some doctors report that people abandon prescriptions because they become unaffordable. Sources also note that the pharmaceutical market is already fragile, and that the latest disruptions deepen existing shortages rather than creating a single new problem. Overall, the reporting describes worsening medicine availability and affordability pressures for patients as the conflict continues.